Cellules souches de moelle osseuse: Nouvelles perspectives en oncologie et hématologie
Cellules souches de moelle osseuse (BMSC) have emerged as a promising frontier in oncology and hematology. Their unique regenerative and immunomodulatory properties offer novel therapeutic avenues for treating hematological malignancies, lésions tissulaires, et troubles immunitaires. This article explores the latest advancements in BMSC research, highlighting their potential in disease management and tissue regeneration.














